Autoimmune Lymphoproliferative Syndrome (ALPS)
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
265-278
Author(s):
Jack J.H. Bleesing
Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
339-353
Author(s):
William A. Denny and Bruce C. Baguley
Transmission and Immunopathogenesis of FIV in Cats as a Model for HIV
Journal:
Current HIV Research
Volume:
1
Page:
15-29
Author(s):
Mary Jo Burkhard and Gregg A. Dean
The Cytokine Network in HIV Infection
Journal:
Current Molecular Medicine
Volume:
2
Page:
677-689
Author(s):
M. Alfano and G. Poli
Innate T-Cell Immunity in HIV Infections: The Role of Vg9Vd2 T Lymphocytes
Journal:
Current Molecular Medicine
Volume:
2
Page:
769-781
Author(s):
F. Poccia, M.- L. Gougeon, C. Agrati, C. Montesano, F. Martini, C. D. Pauza, P. Fisch, M. Wallace and M. Malkovsky
Cytochrome P450-based Gene Therapy for Cancer Treatment: From Concept to the Clinic
Journal:
Current Drug Metabolism
Volume:
3
Page:
609-622
Author(s):
Youssef Jounaidi
Gene Therapy and Biologic Therapy with Interleukin?4
Journal:
Current Gene Therapy
Volume:
2
Page:
437-450
Author(s):
Hideho Okada and Naruo Kuwashima
Immunogenic Issues Concerning Recombinant Adeno-Associated Virus Vectors for Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
485-500
Author(s):
J. Y. Sun, S. Chatterjee, K. K. Wong and Jr.
Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
337-353
Author(s):
B. G. Gabrielli, R. W. Johnstone and N. A. Saunders
Designing Proteins That Work Using Recombinant Technologies
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
285-297
Author(s):
T. J. Graddis, R. L. Remmele Jr. and J. T. McGrew